Author

T. Hode

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. R. Hoover· 3 shared W. R. Chen· 3 shared C. F. Wong· 2 shared K. Liu· 2 shared L. Alleruzzo· 2 shared S. S. K. Lam· 2 shared T. I. Valerio· 2 shared A. D. Medcalf· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

A. R. Hoover

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel biopolymer for mucosal adjuvant against respiratory pathogens

A. R. Hoover, S. More, K. Liu, C. L. West, T. I. Valerio, N. Yu, C. Villalva, A. Kumar, L. Alleruzzo, S. S. K. Lam, T. Hode, M. Zhao, J. F. Papin, W. R. Chen

This study evaluates a novel biopolymer, GC, as a nasal mucosal adjuvant for respiratory vaccines, showing improved immune response and survival in mice compared to Addavax.

bioRxiv · Sep 7, 2022 · PreprintBioengineering

A novel biopolymer synergizes type I IFN and IL-1β production through STING

A. R. Hoover, K. Liu, S. S. K. Lam, C. F. Wong, A. D. Medcalf, X.-H. Sun, T. Hode, L. Alleruzzo, C. Furrer, T. I. Valerio, W. R. Chen

This study shows that GC activates STING and enhances type I IFN and IL-1β production, promoting antitumor and antiviral immune responses.

bioRxiv · Jul 22, 2022 · PreprintCancer Biology

N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2

C. M. Weiss, H. Liu, E. E. Ball, A. R. Hoover, T. S. Wong, C. F. Wong, S. Lam, T. Hode, M. K. Keel, R. M. Levenson, W. R. Chen, L. L. Coffey

N-dihydrogalactochitosan reduces mortality and morbidity in a lethal SARS-CoV-2 mouse model by lowering viral load and improving survival.

bioRxiv · Aug 10, 2021 · PreprintMicrobiology